Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

OBJECTIVE: Adjuvant chemotherapy is necessary for radical resection of intrahepatic cholangiocarcinoma (ICC) with a high risk of recurrence (T2–4, N1). However, its use in the treatment of early-stage ICC remains controversial. This study aimed to investigate the role of adjuvant chemotherapy after...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-hui, Zhao, Chong-yu, Zhou, En-liang, Lin, Xiao-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650851/
https://www.ncbi.nlm.nih.gov/pubmed/36357848
http://dx.doi.org/10.1186/s12885-022-10269-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650851/
https://www.ncbi.nlm.nih.gov/pubmed/36357848
http://dx.doi.org/10.1186/s12885-022-10269-0

Ejemplares similares